The ABHI US Accelerator has seen 20 UK companies already committed to join the 2020 cohort following July’s announcement that the programme will be expanded.
The programme provides a platform for businesses to strengthen and grow their US activities by utilising ABHI’s advice, expertise and connections. Building on the network ABHI has developed in Texas, this next phase delivers a national offering, enabling connections to the network of institutions and hospital groups ABHI has developed across the US.
Paul Benton, managing director, international, ABHI, said: “We are delighted with the response we have seen, which is a direct reflection of the momentum we have built up in the US these past years. That many of the companies from the 2019 cohort will be recommitting next year is extremely positive, and the fact that there is serious interest from a number of new companies demonstrates the impact this programme offers.”
The accelerator can connect UK businesses to in-market specialists, designed to guide companies on critical issues, such as regulation, reimbursement and technology appraisal. The programme also facilitates introductions to hospital executives, clinical champions and supply chain leaders.
Adrian Javes, sales manager at P3 Medical said: “As an SME looking to enter the American market for the first time, the ABHI US Accelerator has been integral to negotiating the complexities of GPO’s and hospital systems. The trade missions have been a fantastic opportunity to pitch our products to a level of hospital management that we would never be able to gain access to.”
Alongside the other ABHI US Accelerator members, P3 Medical will benefit from the full use of ABHI’s dedicated workspace and office at the Dell Medical School in Austin, providing access to their facilities and the support of senior faculty. Companies will also benefit from a nationwide programme of missions to key strategic regions, enabling more personal and lasting ties with the networks ABHI has cultivated over the years.
